We find that CD3xHER2 bsAb‐mediated interaction of resting, nonactivated T‐cells with HER2+ tumor cells is sufficient (1) to eliminate 50% HER2− cells in mixed tumor areas, and (2) to eradicate distant HER2− tumor areas. The gene discussed is ERBB2; the disease is neoplasm.